利用免疫毒素进行导向治疗是生物治疗的一个重要途径。
One strategy for targeted cancer biotherapy is to utilize recombinant immunotoxins.
本文主要综述了免疫毒素在口腔相关疾病生物治疗中应用的研究进展。
The development situation and application prospect of immunotoxin therapy in oral disease are reviewed in this paper.
结论免疫毒素LHRH - PE40对胃癌细胞的增殖状态有明显的抑制作用。
Conclusions LHRH-PE40 has obvious inhibition effect on the proliferation of gastric cell lines.
免疫毒素是近年来新兴的一种特异性靶向治疗药物，由毒素蛋白和载体两部分构成。
Immunotoxin is a novel class of targeted agents in recent years, which is composed of toxin fragment and antibody or cytokine.
该免疫毒素质粒的制备方法包括重组质粒的构建、重组质粒转染的工程菌的制备等步骤。
The preparation process of the immunotoxin plasmid includes the construction of the recombinant plasmid, the preparation of the recombinant transinfected engineering bacterium and other steps.
目的通过静脉注入抗cd4、CD 8免疫毒素及供体可溶性抗原诱导胰岛移植物免疫耐受。
Objective to induce islet grafting tolerance by intravenous injection of anti CD4, anti CD8 immunotoxins and donor soluble antigen.
结果免疫毒素LHRH-PE40对人胃癌细胞系B GC-823的增殖有明显的抑制作用，同时促进了细胞的凋亡。
Results LHRH-PE40 significantly inhibited the proliferation and induced the apoptosis of gastric carcinoma cell line BGC-823.
结果免疫毒素LHRH-PE40对人胃癌细胞系B GC-823的增殖有明显的抑制作用，同时促进了细胞的凋亡。
Results LHRH-PE40 significantly inhibited the proliferation and induced the apoptosis of gastric carcinoma cell line BGC-823.
应用推荐